Description of signatures used in this work.

Signature: signature name; Training dataset: public training data set if used in this work; Validation dataset: public test data set if used in this work; Signature size: reported signature size in the original paper (genes or features):; Training sample size (good + poor): sample size of training data set, separating good and poor prognosis when reported; Training outcome: outcome used to derive the signature; Training platform: platform used for the training data set; Signature validation: type of validation for signature if performed; Independent validation outcome: outcome used for independent validation if performed; Validation results: for each validation performed, accuracy classification measures or association assessing if provided; Reference: PMID and reference for publishing paper. * Frequencies of subgroups were not available. Abbreviations: TMA: tissue microarray; cv: cross-validation; ns: not specified.特征签名：签名名称； 训练数据集：本研究中使用的公开训练数据集（若适用）； 验证数据集：本研究中使用的公开测试数据集（若适用）； 特征签名规模：原始文献中报道的特征签名规模（基因或特征数量）： 训练样本量（预后良好+预后不良）：报道时区分预后良好与预后不良的训练数据集样本量； 训练结局指标：用于推导特征签名的结局指标； 训练平台：训练数据集所使用的检测平台； 特征签名验证：若开展特征签名验证，则说明验证类型； 独立验证结局指标：若开展独立验证，则说明独立验证所使用的结局指标； 验证结果：针对每项开展的验证，若有提供则列出分类准确率指标或关联评估结果； 参考文献：发表文献的PubMed编号（PMID）及完整参考文献信息。 * 亚组频率暂未公开。 缩写说明：TMA（tissue microarray，组织微阵列）；cv（cross-validation，交叉验证）；ns（not specified，未明确说明）。